Hikma Pharmaceuticals PLC

Hikma Posts Solid H1 Results, Reaffirms Strong Growth Outlook For 2025

07 8 2025 00:32:12 提供 NASDAQ US Markets

Hikma Pharma Announces Launch Of Morphine Sulfate Injection In The US

14 7 2025 02:25:12 提供 NASDAQ US Markets

Bio-Thera Solutions And Hikma Pharma Say FDA Approved STARJEMZA Injection

26 5 2025 23:43:27 提供 NASDAQ US Markets

Hikma Pharma Reaffirms FY25 Guidance Amid Strong Start

24 4 2025 00:54:25 提供 NASDAQ US Markets

Axsome Settles Patent Litigation With Hikma Related To Sunosi - Quick Facts

05 3 2025 04:55:56 提供 NASDAQ US Markets

Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg

14 1 2025 05:49:06 提供 NASDAQ US Markets

Hikma Pharma Extends Recall Of Acetaminophen Injection

23 7 2024 00:11:57 提供 NASDAQ US Markets

Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets

16 6 2024 23:45:01 提供 NASDAQ US Markets

Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US

29 4 2024 06:07:49 提供 NASDAQ US Markets

Hikma Pharma FY Profit Increases

22 2 2024 00:52:27 提供 NASDAQ US Markets

Hikma Pharma Launches Pain Relief Injection COMBOGESIC IV In US

05 2 2024 04:48:52 提供 NASDAQ US Markets

Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa

08 1 2024 00:35:52 提供 NASDAQ US Markets

Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15

31 8 2023 22:51:58 提供 NASDAQ Stocks

Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics

03 8 2023 00:46:32 提供 NASDAQ US Markets

Barclays Reiterates Hikma Pharmaceuticals (LSE:HIK) Equal Weight Recommendation

04 5 2023 17:30:46 提供 NASDAQ Stocks

Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1

11 4 2023 23:25:53 提供 NASDAQ US Markets

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

23 2 2023 01:10:05 提供 NASDAQ US Markets

Hikma accuses Amarin of suppressing generic versions of heart pill

22 2 2023 14:13:30 提供 NASDAQ US Markets

Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.

03 1 2023 00:15:34 提供 NASDAQ US Markets

Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma

29 4 2022 20:58:14 提供 NASDAQ US Markets